On August 31st, Silver Fern released the newest version of its revolutionary software as a service product, the Behavior Diagnostic Platform, with an enhanced user experience, improved features to enable faster and more effective workflow, and integration of a new Heart Failure program.
The Behavior Diagnostic Platform, originally released in the commercial market in 2018, leverages 30 years of clinical research and integrates the American Diabetes Association’s 2016 landmark guidelines for prediabetes and diabetes, which emphasize the importance of addressing behavior psychosocial issues. The Behavior Diagnostic Platform features clinically proven techniques for assessing self-management behaviors, psychosocial factors, and social determinants of health, and provides chronic care management teams with previously inaccessible insights to improve treatment plans and achieve better health outcomes for people with chronic diseases.
Version 2.0 of the Behavior Diagnostic Platform includes the company’s newest disease program: Heart Failure. The Heart Failure program applies Silver Fern’s evidence-based techniques for unlocking patients’ individual barriers, goals, and preferences for treatment, and features assessments tailored specifically to patients with Heart Failure.
Additional highlights of the 2.0 release include:
- Streamlined navigation and access to key actions, including module administration, adding a patient, and patient search
- Improved priority notification for completed modules
- New options for sorting and filtering the patient list
- An improved module layout
- New module display states that indicate whether survey results have been viewed and the level of priority of the flagged results
- The ability to save partially completed modules
- A new help center
- An updated look and feel throughout the dashboard and survey interface
Using the Behavior Diagnostic Platform, chronic disease management teams have helped participants achieve clinically significant improvement in diabetes control and other health outcomes, including twice as many patients achieving health targets for weight loss and physical activity; a .5% reduction in HbA1c; and a 7x increase in patient engagement.